Identification of the PKR nuclear interactome reveals roles in ribosome biogenesis, mRNA processing and cell division

Journal of Cellular Physiology

Volumn 229, Issue 8, 2014, Pages 1047-1060

  Blalock, William L ^a,b   Piazzi, Manuela ^c   Bavelloni, Alberto ^b   Raffini, Mirco ^b   Faenza, Irene ^c   D'Angelo, Antonietta ^b   Cocco, Lucio ^c  

^a CNR   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADAR1 PROTEIN; ADARI PROTEIN; BUB3 PROTEIN; EBNAIBP PROTEIN; EIF4A3 PROTEIN; EIF6 PROTEIN; GNL3 PROTEIN; HISTIHIC PROTEIN; HISTONE ACETYLTRANSFERASE; HNRNCPLI PROTEIN; HNRNPC PROTEIN; HUR PROTEIN; INTERLEUKIN ENHANCER BINDING FACTOR 2; INTERLEUKIN ENHANCER BINDING FACTOR 3; LARP1 PROTEIN; LYAR PROTEIN; MYC PROTEIN; NOC3L PROTEIN; NOP2 PROTEIN; NPMI PROTEIN; NUCLEAR PROTEIN; POLDIP3 PROTEIN; PPPICC PROTEIN; PROTEIN KINASE R; RETINOBLASTOMA BINDING PROTEIN 4; RNA HELICASE; THOC2 PROTEIN; TOP1 PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; Y BOX BINDING PROTEIN 1;

ARTICLE; AUTOPHOSPHORYLATION; CELL DIVISION; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME CONDENSATION; CHROMOSOME SEGREGATION; CONTROLLED STUDY; DNA REPLICATION; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LEUKEMIA CELL; M PHASE CELL CYCLE CHECKPOINT; MASS SPECTROMETRY; MESSENGER RNA SYNTHESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA PROCESSING; RNA SPLICING; RNA TRANSLATION; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL CYCLE CHECKPOINTS; CELL DIVISION; CELL NUCLEUS; EIF-2 KINASE; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84899057339     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24529     Document Type: Article

References (52)

1. Bando Y, Onuki R, Katayama T, Manabe T, Kudo T, Taira K, Tohyama M. 2005. Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease. Neurochem Int 46:11-18.
2. Basu S, Panayiotidis P, Hart SM, He LZ, Man A, Hoffbrand AV, Ganeshaguru K. 1997. Role of double-stranded RNA-activated protein kinase in human hematological malignancies. Cancer Res 57:943-947.
3. Bennett RL, Blalock WL, Abtahi DM, Pan Y, Moyer SA, May WS. 2006. RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection. Blood 108:821-829.
4. Blalock WL, Bavelloni A, Piazzi M, Faenza I, Cocco L. 2010. A role for PKR in hematologic malignancies. J Cell Physiol 223:572-591.
5. Blalock WL, Bavelloni A, Piazzi M, Tagliavini F, Faenza I, Martelli AM, Follo MY, Cocco L. 2011. Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress. Leukemia 25:236-245.
6. Blalock WL, Grimaldi C, Fala F, Follo M, Horn S, Basecke J, Martinelli G, Cocco L, Martelli AM. 2009. PKR activity is required for acute leukemic cell maintenance and growth: A role for PKR-mediated phosphatase activity to regulate GSK-3 phosphorylation. J Cell Physiol 221:232-241.
7. Ceci M, Gaviraghi C, Gorrini C, Sala LA, Offenhauser N, Marchisio PC, Biffo S. 2003. Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome assembly. Nature 426:579-584.
8. Chang F, McCubrey JA. 2001. P21(Cip1) induced by Raf is associated with increased Cdk4 activity in hematopoietic cells. Oncogene 20:4354-4364.
9. Couturier J, Morel M, Pontcharraud R, Gontier V, Fauconneau B, Paccalin M, Page G. 2010. Interaction of double-stranded RNA-dependent protein kinase (PKR) with the death receptor signaling pathway in amyloid beta (Abeta)-treated cells and in APPSLPS1 knock-in mice. J Biol Chem 285:1272-1282.
10. Follo MY, Finelli C, Mongiorgi S, Clissa C, Bosi C, Martinelli G, Blalock WL, Cocco L, Martelli AM. 2008. PKR is activated in MDS patients and its subcellular localization depends on disease severity. Leukemia 22:2267-2269.
11. Garcia MA, Collado M, Munoz-Fontela C, Matheu A, Marcos-Villar L, Arroyo J, Esteban M, Serrano M, Rivas C. 2006a. Antiviral action of the tumor suppressor ARF. Embo J 25:4284-4292.
12. Garcia MA, Gil J, Ventoso I, Guerra S, Domingo E, Rivas C, Esteban M. 2006b. Impact of protein kinase PKR in cell biology: From antiviral to antiproliferative action. Microbiol Mol Biol Rev 70:1032-1060.
13. Ghosh M, Aguila HL, Michaud J, Ai Y, Wu MT, Hemmes A, Ristimaki A, Guo C, Furneaux H, Hla T. 2009. Essential role of the RNA-binding protein HuR in progenitor cell survival in mice. J Clin Invest 119:3530-3543.
14. Gouble A, Grazide S, Meggetto F, Mercier P, Delsol G, Morello D. 2002. A new player in oncogenesis: AUF1/hnRNPD overexpression leads to tumorigenesis in transgenic mice. Cancer Res 62:1489-1495.
15. Hann SR, Dixit M, Sears RC, Sealy L. 1994. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. Genes Dev 8:2441-2452.
16. Harashima A, Guettouche T, Barber GN. 2010. Phosphorylation of the NFAR proteins by the dsRNA-dependent protein kinase PKR constitutes a novel mechanism of translational regulation and cellular defense. Genes Dev 24:2640-2653.
17. Hartner JC, Walkley CR, Lu J, Orkin SH. 2009. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol 10:109-115.
18. Jammi NV, Whitby LR, Beal PA. 2003. Small molecule inhibitors of the RNA-dependent protein kinase. Biochem Biophys Res Commun 308:50-57.
19. Jonson L, Vikesaa J, Krogh A, Nielsen LK, Hansen T, Borup R, Johnsen AH, Christiansen J, Nielsen FC. 2007. Molecular composition of IMP1 ribonucleoprotein granules. Mol Cell Proteomics 6:798-811.
20. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. 2002. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 74:5383-5392.
21. Kim SH, Forman AP, Mathews MB, Gunnery S. 2000. Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR. Oncogene 19:3086-3094.
22. Kim SH, Gunnery S, Choe JK, Mathews MB. 2002. Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR. Oncogene 21:8741-8748.
23. Koh HR, Kidwell MA, Ragunathan K, Doudna JA, Myong S. 2013. ATP-independent diffusion of double-stranded RNA binding proteins. Proc Natl Acad Sci USA 110:151-156.
24. Liu X, Bennett RL, Cheng X, Byrne M, Reinhard MK, May WS Jr. 2013. PKR regulates proliferation, differentiation and survival of murine hematopoietic stem/progenitor cells. Blood 121:3364-3374.
25. Ma WJ, Cheng S, Campbell C, Wright A, Furneaux H. 1996. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem 271:8144-8151.
26. Maere S, Heymans K, Kuiper M. 2005. BiNGO: A Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21:3448-3449.
27. Maglott D, Ostell J, Pruitt KD, Tatusova T. 2011. Entrez Gene: Gene-centered information at NCBI. Nucleic Acids Res 39:D52-57.
28. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. 2003. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75:4646-4658.
29. O'Hanlon TP, Rider LG, Gan L, Fannin R, Paules RS, Umbach DM, Weinberg CR, Shah RR, Mav D, Gourley MF, Miller FW. 2011. Gene expression profiles from discordant monozygotic twins suggest that molecular pathways are shared among multiple systemic autoimmune diseases. Arthritis Res Ther 13:R69.
30. Onuki R, Bando Y, Suyama E, Katayama T, Kawasaki H, Baba T, Tohyama M, Taira K. 2004. An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease. Embo J 23:959-968.
31. Pang Q, Keeble W, Diaz J, Christianson TA, Fagerlie S, Rathbun K, Faulkner GR, O'Dwyer M, Bagby GC Jr. 2001. Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon gamma, tumor necrosis factor-alpha, and double-stranded RNA. Blood 97:1644-1652.
32. Paquet C, Bose A, Polivka M, Peoc'h K, Brouland JP, Keohane C, Hugon J, Gray F. 2009. Neuronal phosphorylated RNA-dependent protein kinase in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 68:190-198.
33. Pataer A, Swisher SG, Roth JA, Logothetis CJ, Corn P. 2009. Inhibition of RNA-dependent protein kinase (PKR) leads to cancer cell death and increases chemosensitivity. Cancer Biol Ther 8:245-252.
34. Pfeifer I, Elsby R, Fernandez M, Faria PA, Nussenzveig DR, Lossos IS, Fontoura BM, Martin WD, Barber GN. 2008. NFAR-1 and -2 modulate translation and are required for efficient host defense. Proc Natl Acad Sci USA 105:4173-4178.
35. Ramana CV, Grammatikakis N, Chernov M, Nguyen H, Goh KC, Williams BR, Stark GR. 2000. Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. Embo J 19:263-272.
36. Sharma B, Altman JK, Goussetis DJ, Verma AK, Platanias LC. 2011. Protein kinase R as mediator of the effects of interferon (IFN) gamma and tumor necrosis factor (TNF) alpha on normal and dysplastic hematopoiesis. J Biol Chem 286:27506-27514.
37. Shenoy N, Kessel R, Bhagat TD, Bhattacharyya S, Yu Y, McMahon C, Verma A. 2012. Alterations in the ribosomal machinery in cancer and hematologic disorders. J Hematol Oncol 5:32.
38. Shteynberg D, Deutsch EW, Lam H, Eng JK, Sun Z, Tasman N, Mendoza L, Moritz RL, Aebersold R, Nesvizhskii AI. 2011. iProphet: Multi-level integrative analysis of shotgun proteomic data improves peptide and protein identification rates and error estimates. Mol Cell Proteomics 10:M111.007690.
39. Sjogren SE, Flygare J. 2012. Progress towards mechanism-based treatment for Diamond-Blackfan anemia. ScientificWorldJournal 2012:184362.
40. Starnes LM, Sorrentino A. 2011. Regulatory circuitries coordinated by transcription factors and microRNAs at the cornerstone of hematopoietic stem cell self-renewal and differentiation. Curr Stem Cell Res Ther 6:142-161.
41. Stecklein SR, Jensen RA. 2012. Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology. Transl Res 160:178-197.
42. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, Jensen LJ, von Mering C. 2011. The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39:D561-D568.
43. Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB. 2007. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation. Oncogene 26:1201-1212.
44. UniProt Consortium. 2011. Ongoing and future developments at the Universal Protein Resource. Nucleic Acids Res 39:D214-D219.
45. Vanderweyde T, Youmans K, Liu-Yesucevitz L, Wolozin B. 2013. Role of stress granules and RNA-binding proteins in neurodegeneration: A mini-review. Gerontology 59:524-533.
46. Visconte V, Makishima H, Maciejewski JP, Tiu RV. 2012. Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders. Leukemia 26:2447-2454.
47. Wang IX, So E, Devlin JL, Zhao Y, Wu M, Cheung VG. 2013. ADAR regulates RNA editing, transcript stability, and gene expression. Cell Rep 5:849-860.
48. Wang Q, Khillan J, Gadue P, Nishikura K. 2000. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 290:1765-1768.
49. Weidensdorfer D, Stohr N, Baude A, Lederer M, Kohn M, Schierhorn A, Buchmeier S, Wahle E, Huttelmaier S. 2009. Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs. RNA 15:104-115.
50. XuFeng R, Boyer MJ, Shen H, Li Y, Yu H, Gao Y, Yang Q, Wang Q, Cheng T. 2009. ADAR1 is required for hematopoietic progenitor cell survival via RNA editing. Proc Natl Acad Sci USA 106:17763-17768.
51. Zhang X, Li J, Sejas DP, Rathbun KR, Bagby GC, Pang Q. 2004. The Fanconi anemia proteins functionally interact with the protein kinase regulated by RNA (PKR). J Biol Chem 279:43910-43919.
52. Zhu P, Jiang W, Cao L, Yu W, Pei Y, Yang X, Wan B, Liu JO, Yi Q, Yu L. 2010. IL-2 mRNA stabilization upon PMA stimulation is dependent on NF90-Ser647 phosphorylation by protein kinase CbetaI. J Immunol 185:5140-5149.